Skip to main content

Financial news

The newsroom

Headlines from the Federal Reserve, ECB, Bank of Japan, Bank of England, SEC EDGAR, the White House and the DOJ. Context notes are written automatically by software from each headline, not by an editor. They are neutral and information-only, Kresmion publishes no buy or sell recommendations.

Public RSS feeds · refreshed every 30 minutes

8061 items from SEC EDGAR · clear filters

  • SEC EDGAR•filings
    8-K - Crane Co (0001944013) (Filer)

    Automated noteCrane Co filed a Form 8-K on September 14, 2026, including a Regulation FD disclosure and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Allarity Therapeutics, Inc. (0001860657) (Filer)

    Automated noteAllarity Therapeutics filed a Form 8-K on September 14, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).

  • SEC EDGAR•filings
    8-K - NEWS CORP (0001564708) (Filer)

    Automated noteNews Corp filed a Form 8-K with the SEC on September 14, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).

  • SEC EDGAR•filings
    8-K - TREASURE GLOBAL INC (0001905956) (Filer)

    Automated noteTreasure Global Inc. filed a Form 8-K on September 14, 2026, reporting a material definitive agreement, unregistered sales of equity securities, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Ondas Inc. (0001646188) (Filer)

    Automated noteOndas Inc. filed an 8-K reporting a material definitive agreement, completion of an acquisition, unregistered sales of equity securities, a Regulation FD disclosure, other events, and related financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Onconetix, Inc. (0001782107) (Filer)

    Automated noteOnconetix, Inc. filed a Form 8-K on September 14, 2026, reporting entry into a material definitive agreement, a Regulation FD disclosure, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Federal Home Loan Bank of New York (0001329842) (Filer)

    Automated noteFederal Home Loan Bank of New York filed a Form 8-K on September 14, 2026, reporting other events and providing its financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - Harvard Apparatus Regenerative Technology, Inc. (0001563665) (Filer)

    Automated noteHarvard Apparatus Regenerative Technology, Inc. filed a Form 8-K reporting entry into a material definitive agreement, unregistered sales of equity securities, and the inclusion of financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - NewtekOne, Inc. (0001587987) (Filer)

    Automated noteNewtekOne, Inc. filed a Form 8-K on September 14, 2026, including Item 2.02 on results of operations and financial condition and Item 9.01 with financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Biofrontera Inc. (0001858685) (Filer)

    Automated noteBiofrontera Inc. filed a Form 8-K on September 14, 2026, including Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).

  • SEC EDGAR•filings
    8-K - Cardiff Oncology, Inc. (0001213037) (Filer)

    Automated noteCardiff Oncology, Inc. filed a Form 8-K on September 14, 2026, reporting entry into a material definitive agreement, a Regulation FD disclosure, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - BIOMARIN PHARMACEUTICAL INC (0001048477) (Filer)

    Automated noteBiomarin Pharmaceutical Inc. filed a Form 8-K reporting the departure of certain directors or officers and the appointment of new officers, along with related compensatory arrangements for those officers.

  • SEC EDGAR•filings
    8-K - Ellington Financial Inc. (0001411342) (Filer)

    Automated noteEllington Financial Inc. filed a Form 8-K on September 14, 2026, reporting other events under Item 8.01 and providing financial statements and related exhibits under Item 9.01.

  • SEC EDGAR•filings
    8-K - HEALTHSTREAM INC (0001095565) (Filer)

    Automated noteHealthStream Inc. filed a Form 8-K on September 14, 2026, reporting entry into a material definitive agreement, creation of a direct financial obligation or off-balance-sheet arrangement, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Baldwin Insurance Group, Inc. (0001781755) (Filer)

    Automated noteBaldwin Insurance Group, Inc. filed a Form 8-K on September 14, 2026, reporting entry into a material definitive agreement, a Regulation FD disclosure, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - XBP Global Holdings, Inc. (0001839530) (Filer)

    Automated noteXBP Global Holdings, Inc. filed a Form 8-K reporting a material definitive agreement, unregistered sales of equity securities, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - TransDigm Group INC (0001260221) (Filer)

    Automated noteTransDigm Group Inc. filed a Form 8-K with the SEC on September 14 2026, under Item 7.01, providing a Regulation FD disclosure.

  • SEC EDGAR•filings
    8-K - A10 Networks, Inc. (0001580808) (Filer)

    Automated noteA10 Networks, Inc. filed a Form 8-K reporting the departure of certain directors or officers, the election or appointment of new directors and officers, and disclosed compensatory arrangements for the appointed officers.

  • SEC EDGAR•filings
    8-K - TransDigm Group INC (0001260221) (Filer)

    Automated noteTransDigm Group Inc. filed a Form 8-K with the SEC on September 14, 2026, under Item 7.01, providing a Regulation FD disclosure.

  • SEC EDGAR•filings
    8-K - IMMERSION CORP (0001058811) (Filer)

    Automated noteImmersion Corp filed a Form 8-K on September 14, 2026, containing Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits).

  • SEC EDGAR•filings
    8-K - Celularity Inc (0001752828) (Filer)

    Automated noteCelularity Inc. filed a Form 8-K with the SEC on September 14 2026, reporting under Item 8.01 (Other Events).

  • SEC EDGAR•filings
    8-K - Phio Pharmaceuticals Corp. (0001533040) (Filer)

    Automated notePhio Pharmaceuticals Corp. filed a Form 8-K on September 14, 2026 (accession 0001437749-26-030236), reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).

  • SEC EDGAR•filings
    8-K - Quantum X Inc. (0001494413) (Filer)

    Automated noteQuantum X Inc. filed a Form 8-K on September 14, 2026, reporting Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits.

  • SEC EDGAR•filings
    8-K - Hyperliquid Strategies Inc (0002078856) (Filer)

    Automated noteHyperliquid Strategies Inc filed a Form 8-K on September 14, 2026, reporting entry into a material definitive agreement and providing its financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - SmartKem, Inc. (0001817760) (Filer)

    Automated noteSmartKem, Inc. filed a Form 8-K reporting a notice of delisting or failure to satisfy a continued listing rule and a transfer of its listing.

  • SEC EDGAR•filings
    8-K - Future Vision II Acquisition Corp. (0002010653) (Filer)

    Automated noteFuture Vision II Acquisition Corp filed a Form 8-K reporting a material definitive agreement, a direct financial obligation/off-balance sheet arrangement, unregistered equity sales, other events, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - BITMINE IMMERSION TECHNOLOGIES, INC. (0001829311) (Filer)

    Automated noteBitmine Immersion Technologies, Inc. filed a Form 8-K on September 14, 2026, including a Regulation FD disclosure and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - ClearSign Technologies Corp (0001434524) (Filer)

    Automated noteClearSign Technologies Corp filed a Form 8-K on September 14, 2026, containing a Regulation FD disclosure (Item 7.01) and its financial statements and related exhibits (Item 9.01).

  • SEC EDGAR•filings
    8-K - Summit Therapeutics Inc. (0001599298) (Filer)

    Automated noteSummit Therapeutics Inc. filed a Form 8-K on September 14, 2026 (AccNo 0001599298-26-000078, 2 MB), containing Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits.

  • SEC EDGAR•filings
    8-K - Bowman Consulting Group Ltd. (0001847590) (Filer)

    Automated noteBowman Consulting Group Ltd. filed a Form 8-K on September 14, 2026, including Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits) under accession number 0001193125-26-389902.